SOLIFENACIN SUCCINATE
Generic: SOLIFENACIN SUCCIATE, SOLIFENACIN SUCCINATE
Bostal LLCManufacturer
ORALRoute
SOLIFENACIN SUCCINATEActive Substance
2019-05-20Original Approval
SOLIFENACIN SUCCINATE is FDA application ANDA210281, sponsored by BOSTAL. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2025-03-13
Solifenacin Succinate Tablets 5mg, a.) 30-count bottle (NDC# 68462-386-30) b.) 90-count bottle (NDC# 68462-386-90), Rx OCGMP Deviations
Class II2025-03-13
Solifenacin Succinate Tablets 10MG, a. 30-count bottle (NDC# 68462-387-30), b. 90-Count Bottle (NDC 68462-387-90),Rx OnCGMP Deviations
Top Reported Reactions
1
FATIGUE
140 reports
2
FALL
127 reports
3
DIZZINESS
118 reports
4
CONSTIPATION
96 reports
5
DRUG INEFFECTIVE
96 reports
6
MALAISE
94 reports
7
DIARRHOEA
91 reports
8
HYPOTENSION
90 reports
9
GAIT DISTURBANCE
86 reports
10
NAUSEA
86 reports